Earnings Summary

Laboratory Corp. Of America Holdings’s revenue fell -17.44% since last year same period to $3033.3Mn in the Q4 2023. On a quarterly growth basis, Laboratory Corp. Of America Holdings has generated -0.77% fall in its revenue since last 3-months.

Laboratory Corp. Of America Holdings’s net profit fell -319.58% since last year same period to $-167.1Mn in the Q4 2023. On a quarterly growth basis, Laboratory Corp. Of America Holdings has generated -191.16% fall in its net profits since last 3-months.

Laboratory Corp. Of America Holdings’s net profit margin fell -365.97% since last year same period to -5.51% in the Q4 2023. On a quarterly growth basis, Laboratory Corp. Of America Holdings has generated -191.87% fall in its net profit margins since last 3-months.

Laboratory Corp. Of America Holdings’s earning per share (EPS) estimates for the current quarter stand at 3.48 - a 6.75% jump from last quarter’s estimates.

Laboratory Corp. Of America Holdings’s earning per share (EPS) estimates for the current year stand at 3.48.

Laboratory Corp. Of America Holdings’s earning per share (EPS) fell -20.29% since last year same period to 3.3 in the Q4 2023. This indicates that the Laboratory Corp. Of America Holdings has generated -20.29% annual rate of fall in its earning per share (EPS) in the last 4 quarters.

Laboratory Corp. Of America Holdings declared 0.72 dividend per share during the earnings announcement for Q4 2023.